NIH-funded research R01 grant

Speech and language tools to detect Alzheimer's and frontotemporal dementia in Spanish and English speakers

Official title: An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations

Funded at University of California, San Francisco · NIH-11404657 · Data updated 2026-11-12

Using short natural speech recordings, researchers will look for sound and language patterns that can help detect Alzheimer's disease and frontotemporal dementia in Spanish-speaking Latinos and English-speaking adults.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 15, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$279,559
NIH project number3R01AG075775-03S3
Project IDNIH-11404657 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are Spanish-speaking Latinos and English-speaking adults with diagnosed or suspected Alzheimer's disease or frontotemporal dementia, as well as healthy control volunteers willing to provide speech samples.

Less likely to help

People without cognitive concerns or those with neurological conditions not related to Alzheimer's disease or frontotemporal dementia may not receive direct benefit from this project.

What this research studies

You would be asked to produce natural speech (conversation, storytelling, or similar tasks) while being recorded so acoustic and word-level features can be extracted. Those digital features will be analyzed with automated speech and language methods and machine learning to find patterns that distinguish Alzheimer's disease from frontotemporal dementia and from healthy aging. The project includes large groups of Spanish speakers from five Latin American countries and English speakers in the US and will account for factors like bilingualism, sex, and brain profile. Researchers will also compare speech markers with standard clinical measures to test how well speech-based signals match established evaluations.

Why it matters

Potential benefit: Could enable low-cost, scalable speech-based screening and monitoring tools that make earlier and more accessible detection of AD and FTD possible for Spanish- and English-speaking patients.

How similar studies have gone: Previous automated speech and language studies have shown promising signals for detecting dementia but have typically been small and focused on English, so this multilingual, large-scale effort builds on encouraging but not yet definitive evidence.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Gorno Tempini, Maria Luisa — University of California, San Francisco
  • Study coordinator: Gorno Tempini, Maria Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.